Clinical Research Studies
We do research across every area of cardiovascular care. Our research offers hope for patients, options to discuss with your doctor, and opportunities to make a difference for future patients. See the search below for a list of our active and enrolling clinical research studies and see if you may qualify to participate.
Benefits of Research
Be More Active
Take a more active role in your own health care.
Potential to Unlock More Options
You may gain access to investigational treatments and medications.
Make a Contribution
Help find a new and better way to treat people with your condition.
Search for research studies
Victorion-InceptionStudy Investigator:
Thomas Knickelbine, MD
About the Study:The purpose of this study is to study the effectiveness of implementation of a systematic LDL-C management pathway including treatment with inclisiran in participants who have experienced a recent acute coronary syndrome (ACS) and have an increased LDL-cholesterol (≥70 mg/dL) despite being treated with a statin drug. Condition:
Other
|
View Study |
The CORCINCH-HF StudyStudy Investigator:
Peter Eckman, MD
About the Study:Prospective, randomized, open-label, international, multi-center clinical study to evaluate the safety and efficacy of the AccuCinch Ventricular Restoration System in patients with heart failure and reduced ejection fraction (HFrEF). Condition:
Heart Failure, Cardiomyopathy
|
View Study |
SGLT2Study Investigator:
Jay Traverse, MD
About the Study:The purpose of the research is to determine whether a medication called dapagliflozin will improve the heart's function and reduce its enlargement after a heart attack. Participation in this study will involve taking the medication dapagliflozin (or a placebo) once daily for six months, one cardiac magnetic resonance imaging (MRI) test during your initial hospitalization, follow-up phone calls at 1 and 3 months, and one cardiac MRI and clinic visit at six months. Condition:
NSTEMI/STEMI (Heart Attack)
|
View Study |
OHP PAS RegistryStudy Investigator:
Benjamin Sun, MD
About the Study:The objective of this post-approval registry is to provide additional real-world evidence of the performance of the OCS Heart System to preserve DBD donor hearts. Condition:
Heart Failure
|
View Study |
MGH HALTStudy Investigator:
Joao Cavalcante, MD
About the Study:The purposes of the HALT Biomarkers study are to identify a panel of circulating proteins that discriminates between patients with and without Hypo-Attenuated Leaflet Thickening (HALT) and can be used to supplement the diagnosis of HALT; to characterize changes in circulating proteins after treatment of HALT with systemic anticoagulation; and to identify circulating proteins that predict the occurrence of HALT. Condition:
Valvular Disease (Heart Valve Disease)
|
View Study |